4 active not recruiting. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Active not recruiting 4 |
Follow Anemia: new trials by email Literature Review of Anemia trials Research Report on Anemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Daily Versus Alternate Day Regimen of Iron Supplementation in Children with Iron Deficiency Anemia ferric hydroxide polymaltose complex, Albendazole. - Iron Deficiency Anemia Treatment | Phase 4 | Active not recruiting | Ain Shams University | 72 | 2024-01-01 | 2024-10-08 |
| Effects of the Contraceptive Implant in Women With Sickle Cell Disease Nexplanon 68 MG Drug Implant - Sickle Cell Disease | Phase 4 | Active not recruiting | University of Pennsylvania | 22 | 2023-08-02 | 2026-06-12 |
| A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India Luspatercept - Anemia | Phase 4 | Active not recruiting | Bristol-Myers Squibb | 85 | 2023-06-05 | 2026-08-31 |
| CINC424A2X01B Rollover Protocol ruxolitinib, panobinostat - Primary Myelofibrosis, Polycythemia Vera | Phase 4 | Active not recruiting | Novartis Pharmaceuticals | 279 | 2015-03-05 | 2026-10-19 |
Anemia, Sickle Cell (1) · Bone Marrow Diseases (1) · Bronchiolitis Obliterans Syndrome (1) · Graft vs Host Disease (1) · Hematologic Diseases (1) · Hemoglobinopathies (1) · Leukemia, Myeloid, Acute (1) · Polycythemia Vera (1) · Primary Myelofibrosis (1) · Thalassemia (1) · beta-Thalassemia (1)
Hemic and Lymphatic Diseases (4) · Anemia, Hemolytic (3) · Anemia, Hemolytic, Congenital (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Hematologic Diseases (3) · Hemoglobinopathies (2) · Bone Marrow Diseases (1) · Bone Marrow Neoplasms (1) · Bronchial Diseases (1) · Bronchiolitis (1) · Bronchiolitis Obliterans (1) · Bronchitis (1) · Hematologic Neoplasms (1)
Albendazole (1) · Drug Implants (1) · Panobinostat (1) · etonogestrel (1) · luspatercept (1) · ruxolitinib (1)
Ain Shams University (1) · Bristol-Myers Squibb (1) · Novartis Pharmaceuticals (1) · University of Pennsylvania (1)
India (2) · Australia (1) · Belgium (1) · Bulgaria (1) · Canada (1) · Chile (1) · China (1) · Egypt (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · Israel (1) · Italy (1) · Japan (1)
2014 (1)